MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Adult onset of Dandy-Walker Syndrome

    J. Sinelli, I. Cristea, C. Toader, N. Paun (Bucharest, Romania)

  • Advance Care Planning in Complex Stage Parkinson’s Disease

    M. Khwaja, A. Chatterjee, H. Avery, C. James (Reading, United Kingdom)

  • Advance Care Planning in Parkinson’s Disease – Are we getting it right?

    C. Grose, C. Thomas, B. Mohamed, R. Patten (Cardiff, United Kingdom)

  • Age and gender differences in cardiovascular autonomic failure in transgenic PLP-syn mouse model of multiple system atrophy

    M. Kermorgant, D. Arvanitis, P.O Fernagut, W. Meissner, J.M Senard, C. Galès, A. Pavy-Le Traon (Toulouse, France)

  • Age at onset and Parkinson’s disease progression

    G. D'Urso, K. Taylor, T. Kustermann, N. Pavese, G. Pagano (Basel, Switzerland)

  • Age-dependent expression of α-synuclein and its modification in non-neurodegenerative intestinal tract

    L. Bu, K. Huang, Y. Liang, S. Peng, Y. Chen (Guangzhou, China)

  • Agreement Between Neurologists on UPDRS Scoring and Symptom Laterality

    E. Smith, J. Bertoni, D. Bhatti (Omaha, NE, USA)

  • Alexithymia is associated with worse quality of life and caregiver burden in people with Parkinson’s disease

    M. Klietz, T. Schnur, S.C Drexel, F. Lange, L. Paracka, D. Dressler, G.U Höglinger, F. Wegner (Hannover, Germany)

  • Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease

    G. Kenangil, M. Demir, E. Tur, F. Domaç (Istanbul, Turkey)

  • All-cause mortality in pimavanserin and atypical antipsychotic users with Parkinson’s disease in Medicare

    A. Mosholder, Y. Ma, S. Akhtar, G. Podskalny, Y. Wei, J. Liao, Y. Feng, H. Lyu, M. Wernecke, K. Leishear, L. Nelson, T. MaCurdy, J. Kelman, D. Graham (Silver Spring, MD, USA)

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley